Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte proliferation refers to the process by which keratinocytes, the predominant cell type in the epidermis, divide and multiply. Suppression of this proliferation is a key therapeutic target in conditions characterized by excessive skin cell growth, such as psoriasis and certain skin cancers. Key signaling pathways involved include PKC, mTOR, MAPK/AP1, and PI3K/AKT/mTOR/NFκB. Agents that upregulate cell cycle inhibitors (e.g., p21^Cip1^) or disrupt cellular metabolism can effectively suppress keratinocyte proliferation.
Inhibition of keratinocyte proliferation through various mechanisms, including cell cycle arrest, modulation of signaling pathways (MAPK, PI3K/AKT/mTOR, PKC), and metabolic disruption.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte Proliferation (Suppression).